Final decision on the creation of a new cardiovascular board expected soon

 

The fate of the proposed American Board of Cardiovascular Medicine (ABCVM) is expected to be decided soon when the American Board of Medical Specialties (ABMS) announces its final review. If approved, it would be the first new medical board created in the past 30 years and finally launch cardiology as an independent specialty, separating it from the American Board of Internal Medicine (ABIM).

"Cardiology has evolved into its own specialty. It felt like our voices were not necessarily being heard within the ABIM. We thought it was time because our specialty is independent enough and big enough that we could have our own, say in our own certification process," explained Christopher M. Kramer, MD, vice president of the American College of Cardiology (ACC) and the incoming 2025 ACC president, in a video interview with Cardiovascular Business during the American Heart Association (AHA) 2024 meeting.

He said cardiology has evolved over the past 50 years as an offshoot of internal medicine and now has multiple subspecialties of its own.

The effort to create the new cardiology board is being led by a coalition of leading cardiovascular societies. It is spearheaded by the ACC in collaboration with the American Heart Association (AHA), Heart Failure Society of America (HFSA), Heart Rhythm Society (HRS), and the Society for Cardiovascular Angiography and Interventions (SCAI).

Cardiologists are currently certified through the ABIM, which has historically governed internal medicine and its subspecialties. However, increasing dissatisfaction among cardiologists has fueled the push for independence. One major concern has been the financial burden and complexity of the recertification process under the ABIM. According to Kramer, the criteria for recertification have become increasingly onerous, with mounting costs and unexpected policy changes.

For decades, cardiologists who trained before 1990 were "grandfathered in," meaning they were not required to recertify. However, a sudden policy shift by the ABIM removed these exemptions, forcing long-practicing cardiologists to undergo costly and time-consuming recertification.

"Out of nowhere, the ABIM changed those rules and removed the grandfathering clauses. So people who hadn't needed to recertify for 35 years suddenly we're asked to pay additional funds for getting a piece of paper saying you're certified and starting the testing process for recertification," he said.

Beyond financial concerns, the methodology of the ABIM’s certification exams has also been criticized. Kramer pointed out that the current system is largely punitive, pass-fail testing rather than a informative process that identifies areas for improvement.

The testing plan by the new ABCVM is the opposite, he said.  By answering questions, it will show clear areas of weakness where a physician needs to brush up on their knowledge. ABIM also plans to use other data such as patient evaluations and outcomes to determine how a cardiologist is performing.

Another major issue cardiologists face under the ABIM is the broad scope of the recertification exam. Cardiology has become increasingly specialized, with fields such as electrophysiology, interventional cardiology, congenital heart, and heart failure each requiring distinct expertise. These require separate tests that ask questions specific to those areas, not a broad set of questions that are outside the primary cardiology scope of the person being tested, and especially not being asked internal medicine questions.

"Many of us who are cardiologists don't maintain certification in internal medicine, because we don't practice internal medicine day-to-day, we practice cardiology," Kramer said, stressing cardiologists should not be tested on things that are not relevant to their practice.

"Cardiologists are so specialized now that questions that might be important for a heart failure specialist may not be important for an electrophysiologist. And so people practice their specialties and may not have necessarily kept up with the latest in structural heart disease because they don't need to, don't use that data day-to-day," he added

ABMS is now performing its final review of this proposal. A final decision is expected by the end of February. 

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.